Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)

Market Cap	14.97B -15.1%
Revenue (ttm)	1.75B -4.7%
Net Income	266.34M +45.2%
EPS	0.28 +38.3%
Shares Out	928.16M
PE Ratio	57.72
Forward PE	n/a
Dividend	0.12 (0.75%)
Ex-Dividend Date	n/a

Volume	16,536,478
Average Volume	17,140,524
Open	16.74
Previous Close	16.13
Day's Range	16.21 - 17.74
52-Week Range	13.38 - 29.00
Beta	0.21
RSI	61.72
Earnings Date	Apr 29, 2026

About SHE:002755

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 799
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002755

Financial Performance

In 2025, SHE:002755's revenue was 1.78 billion, an increase of 0.08% compared to the previous year's 1.78 billion. Earnings were 236.60 million, an increase of 47.60%.